Amber Implants Announces Successful One-Year Follow-Up Data in First-in-Human Clinical Trial of VCFix® Spinal System
OrthoSpineNews
JUNE 3, 2025
Notably, no device-related adverse events were reported in any patient at the one-year follow-up, underscoring the strong safety profile and promising clinical potential of VCFix. In addition, significant improvements in key clinical performance outcomes were observed, regardless of cement augmentation. ” said Prof.
52 
Let's personalize your content